Crinetics Pharmaceuticals Inc (CRNX)
45.33
-1.56
(-3.33%)
USD |
NASDAQ |
Jun 14, 16:00
45.31
-0.02
(-0.04%)
After-Hours: 20:00
Crinetics Pharmaceuticals Revenue (Quarterly): 0.64M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.64M |
| December 31, 2023 | |
| September 30, 2023 | 0.346M |
| June 30, 2023 | 0.988M |
| March 31, 2023 | 2.679M |
| Date | Value |
|---|---|
| December 31, 2022 | 0.709M |
| September 30, 2022 | 0.458M |
| June 30, 2022 | 0.439M |
| March 31, 2022 | 3.131M |
| December 31, 2021 | 1.078M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.346M
Minimum
Sep 2023
3.131M
Maximum
Mar 2022
1.163M
Average
0.709M
Median
Dec 2022
Revenue (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 98.51M |
| Geron Corp | 0.304M |
| Madrigal Pharmaceuticals Inc | -- |
| PTC Therapeutics Inc | 210.12M |
| Syndax Pharmaceuticals Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -66.93M |
| Total Expenses (Quarterly) | 74.17M |
| EPS Diluted (Quarterly) | -0.93 |
| Enterprise Value | 2.674B |
| Profit Margin (Quarterly) | -10.46K% |
| Earnings Yield | -8.34% |
| Normalized Earnings Yield | -8.339 |